<--- Back to Details
First PageDocument Content
Carbamates / Gilead Sciences / Organofluorides / Fixed dose combination / Darunavir / Antiretroviral drug / Efavirenz / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Chemistry / Organic chemistry / Protease inhibitors
Date: 2013-06-10 11:00:25
Carbamates
Gilead Sciences
Organofluorides
Fixed dose combination
Darunavir
Antiretroviral drug
Efavirenz
Emtricitabine/tenofovir/efavirenz
Tenofovir/emtricitabine
Chemistry
Organic chemistry
Protease inhibitors

PI S NRTI COMBINATIONS Dietary restriction

Add to Reading List

Source URL: www.hivmedicationguide.com

Download Document from Source Website

File Size: 984,19 KB

Share Document on Facebook

Similar Documents

Carbamates / Organofluorides / Gilead Sciences / Organochlorides / Alkynes / Darunavir / Antiretroviral drug / Tenofovir/emtricitabine / Lamivudine / Chemistry / Organic chemistry / Pharmacology

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

DocID: 1gtlL - View Document

Telaprevir / Efavirenz / Nelfinavir / Ritonavir / Darunavir / Atazanavir / Saquinavir / Hepatitis C virus / Lopinavir / Chemistry / Organic chemistry / Protease inhibitors

SUPPLEMENT ARTICLE Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs Stefan Mauss1 and Hartwig Klinker2 1

DocID: 1giaR - View Document

Antiretroviral drug / Lopinavir/ritonavir / Darunavir / Lopinavir / Efavirenz / Atazanavir / Saquinavir / HIV / Viral load / Chemistry / Organic chemistry / Protease inhibitors

AIDS Research and Therapy BioMed Central Research

DocID: 1aNo3 - View Document

Organofluorides / Merck / Carbamates / Schering-Plough / Statin / Ezetimibe / Fenofibrate / Ritonavir / Darunavir / Chemistry / Organic chemistry / Protease inhibitors

MS&D logo_no qualifier_2 lines

DocID: 1a8lZ - View Document

Sulfonamides / Medicine / Carbamates / Darunavir / HIV/AIDS / Antiretroviral drug / ViiV Healthcare / Zidovudine / Integrase inhibitor / Protease inhibitors / Chemistry / Biology

Data from the FLAMINGO Phase IIIb/IV Study of the Integrase Inhibitor Tivicay® (dolutegravir), Disclosed by ViiV Healthcare Osaka, Japan, September 13, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: I

DocID: 1a178 - View Document